Pertuzumab is used to treat HER2-positive breast cancer.
It is a monoclonal antibody which targets HER2, a certain type of protein on the surface of cancer cells, to control their growth.
Inform your healthcare professional if:
If you experience any of these symptoms, you should stop your medication and see your healthcare professional immediately.
You may refer to the following website if you need more information: https://www.macmillan.org.uk/
Disclaimers
Please take note that the above is not a complete list of all possible side-effects. If you have any concerns about your medication or if you have other side-effects that you think are caused by this medication, please consult your doctor or pharmacist. If you take more than the recommended dose, please seek medical advice immediately. The information provided on this page does not replace information from your healthcare professional. Please consult your healthcare professional for more information.
This article is jointly developed by members of the National Medication Information workgroup. The workgroup consists of cluster partners (NHG Health, National University Health System and SingHealth), community pharmacies (Guardian, Unity and Watsons) and Pharmaceutical Society of Singapore. The content does not reflect drug availability and supply information in pharmacies and healthcare institutions. You are advised to check with the respective institutions for such information.
Use Medicine Order Service on HealthBuddy.
Get reminders and chart progress on HealthBuddy.
Related Conditions or Treatments